Lexaria Bioscience Corp. — Director's Dealing 2024

Jul 30, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lexaria Bioscience Corp. (LEXX)
CIK: 0001348362
Period of Report: 2024-07-26

Reporting Person: REESE ALBERT L JR (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-07-26	Stock Options	$3.39	A	12000	Acquired	2029-07-26	Common Shares (12000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
common shares	10917	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$3	2026-02-01	Common Shares (3400)	3400	Direct
Stock Options	$3.39	2027-03-08	Common Shares (3400)	6800	Direct
Stock Options	$1.96	2027-10-12	Common Shares (3200)	10000	Direct
Stock Options	$0.87	2028-07-25	Common Shares (5000)	15000	Direct
Stock Options	$2.36	2029-04-26	Common Shares (5000)	20000	Direct

Footnotes

F1: Repriced from $4.80 pursuant to shareholder approval received on May 9, 2023